Clinical Trial Update: A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled trial evaluated the safety of INCB054707 in participants with hidradenitis suppurativa; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• INCB054707

Snippet

Sponsor: Incyte Corporation | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2020-09-21